English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Objective  To assess adherence to 3 system‐level performance measures in a national early rheumatoid arthritis ( RA ) cohort.    Methods  Patients enrolled in the Canadian Early Arthritis Cohort (2007–2015) who met 1987 or 2010 American College of Rheumatology/European League Against Rheumatism criteria with <1 year of symptom duration and ≥1 year of followup after enrollment were included. Performance measures assessed were the percentage of  RA  patients seen in yearly followup, and the number of gaps between visits of >12 or >14 months, the percentage of  RA  patients treated with a disease‐modifying antirheumatic drug ( DMARD ), and days from  RA  diagnosis to initiation of a  DMARD . Results are shown stratified by enrollment year to assess for temporal changes in performance.    Results  A total of 1,763 early  RA  patients were included (mean age 54 years, 73% female, and 82% white). At enrollment, mean ±  SD  disease duration was 6 ± 3 months, and Disease Activity Score in 28 joints was 5.1 ± 1.5. Over 8 years, the proportion of patients seen in annual followup declined from 100% to 91%. Over followup, 42% of patients had 0 gaps in care of >12 months, and 64% had 0 gaps >14 months. The percentage of  DMARD ‐treated early  RA  patients was and remained high (95–87%), and the percentage receiving  DMARD s within 14 days of diagnosis was 75%. Median time‐to‐ DMARD  therapy was 1 day, indicating  DMARD s were initiated at diagnosis (90th percentile 93 days).    Conclusion  There was evidence of high adherence to system‐level performance measures in this early  RA  cohort following a protocol. Small declines in performance were noted with increasing length of patient followup. Our findings are useful for performance measure benchmarking.

High Adherence to System‐Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years